The Gross Law Firm has issued a shareholder alert for Embecta Corp., announcing that investors who purchased EMBC shares between November 25, 2025 and May 4, 2026 may seek lead plaintiff appointment in a securities class action. The lawsuit alleges that Embecta made materially false and misleading statements about its fiscal results, touting its pen needle business as "incredibly resolute" just weeks before missing expectations and cutting fiscal 2026 guidance. On May 5, 2026, the company reported second-quarter results showing a revenue decline of over 14%, far worse than its prior guidance of flat to a 2% decline, and lowered its full-year outlook, citing weakness in U.S. pen needle sales. Following the disclosure, Embecta's stock fell from $9.25 per share to $3.90 per share, a single-day drop of over 57.8%. The deadline to apply for lead plaintiff is August 17, 2026.
Embecta CorpLawsuit alleges false statements about fiscal results; stock dropped 57.8% after missing guidance.